Data mining in health and medical information by Bath, P.A.
promoting access to White Rose research papers 
   
White Rose Research Online 
eprints@whiterose.ac.uk 
 
 
 
Universities of Leeds, Sheffield and York 
http://eprints.whiterose.ac.uk/ 
 
 
 
This is an author produced version of a paper published in Annual Review of 
Information Science and Technology. 
 
 
White Rose Research Online URL for this paper: 
http://eprints.whiterose.ac.uk/78628  
 
 
 
Published paper 
 
Bath, P.A. (2004) Data mining in health and medical information. Annual Review 
of Information Science and Technology, 38 (1). 331 - 369. 
http://dx.doi.org/10.1002/aris.1440380108 
 
Data mining in health and medical information 
Peter A. Bath 
Introduction 
Data mining (DM) is part of a process by which information or knowledge can be extracted from 
data or databases and used to inform decision-making in a variety of contexts (Michalski et al., 
1997; Benoit, 2002). The process of DM includes a range of tools and methods for extracting this 
information and one of the main driving forces for the development of DM tools has been their use 
in the commercial sector for knowledge extraction and discovery in commercial/ business 
applications (Adriaans and Zantige, 1996; Benoit, 2002). However, DM has been developed and 
applied in a number of different areas and the purpose of this review is to describe and discuss one 
such application area, the use of DM for analysing health and medical information.  
Several reviews of DM have appeared in ARIST over the last few years (Trybula, 1997; Trybula, 
1999; Benoit, 2001), and this review complements these by exploring the use of DM in the specific 
domain of health and medical practice and research and examines the features of this domain and its 
particular suitability for DM in the problems specific to this area. A number of general reviews of 
the application of DM tools in the health and medicine have recently been published (e.g., Maojo 
and Sanandrés, 2000; Lavra  N, 1999a; Horn, 2001; Pe a-Reyes and Sipper, 2000; McSherry, 
1999) as well as more specific reviews of the use and effectiveness of particular tools and methods 
in this domain, mainly artificial neural networks (Baxt, 1995; Cross et al., 1995; Dybowski and 
Gant, 1995; Lisboa, 2002; Liestol et al., 1994; Tu, 1996) but also machine learning methods 
(Lavra , 1999b) and computer-based clinical decision support systems (Johnston et al., 1994). In 
addition this review considers the importance of statistics in the DM process, and numerous general 
statistics texts are available and accessible to non-statisticians with an interest in analysing health 
and medical information (Altman, 1991; Bland, 2000; Daly and Bourke, 2000). This review 
provides an overview of the range of DM tools that have been applied in health and medicine and 
examines the issues that are affecting their development and uptake as part of routine clinical 
practice in this domain. 
Scope and limitations of the review  
Recent ARIST reviews of DM have discussed mining of structured data (Trybula, 1997), textual 
data (Trybula, 1999) and DM as part of the knowledge discovery process (Benoit, 2001) and these 
have considered applications of DM in different contexts and domains. This review will only 
describe those tools that have been used for mining data in health and medicine, and will discuss the 
issues that make these data suitable for DM and the factors affecting their use. The review will not 
consider developments in DM in other application areas, nor will it compare the use of DM 
techniques within health and medicine in relation to these areas. Although what is described for 
health and medical research may be equally true of other areas in which DM has been or might be 
applied, and there may be comparisons and contrasts in the application of DM in the 
medicine/health domain and other areas, discussion of these is beyond the scope of this review. The 
use of DM techniques in areas closely related to medicine and health, e.g., analysing genomic 
databases in bioinformatics etc., are outside the scope of the review and will not be discussed here. 
Reviews discussing the role of DM in this field have recently been published (Bertone and Gerstein, 
2001; Luscombe et al., 2001; Miller 2000). The review will focus on DM tools for analysing 
numeric quantitative data in health and medicine and will not consider DM tools such as HINT and 
DEX developed to process qualitative data (Bohanec et al., 2000) or the mining of text data in this 
domain (Trybula, 1999; Swanson, 1987; Swanson and Smalheiser, 1999). Within the health and 
medical domain the review will consider the application of DM tools in medical and health care 
practice and research and will not describe application of DM tools in laboratory environments; a 
useful, if now somewhat dated, review by Dybowski and Gant (1995) discussed the use of artificial 
neural networks in pathology and medical laboratories and Jones (2001) recently reviewed the use 
of data mining for identifying adverse events in clinical trials and adverse events databases. In 
undertaking the review a considerable number of research articles reporting applications of DM in 
the computing, health and medical literature were retrieved. Search terms were developed to cover 
the range of DM methods and tools that have been adopted within health and medicine, including 
DM, artificial neural networks, machine learning, decision trees, rule-based, 
evolutionary, genetic algorithms, etc. The retrieved results were examined and filtered to 
achieve an appropriate balance of review and original empirical research publications that was 
representative of the techniques that have been used and the areas in which they have been applied. 
The scope and contents of this review are therefore intended to reflect the use of DM tools in the 
health and medicine. Although the methods outlined above are predominantly developed from 
artificial intelligence, the importance of descriptive and inferential statistics in the DM process will 
be discussed and the review will consider both statistical and non-statistical methods of analysing 
data and the relationship between them. The review commences with a discussion of the various 
definitions of DM and ho 
Definitions of DM 
Various definitions of DM and synonyms for it have emerged in recent years that are not wholly 
consistent with each other (Benoit, 2001), which have created some confusion and suspicion in 
health and medicine, and this review will attempt to clarify what DM is, and equally importantly, 
what it is not. Benoit (2001, p.265) in his recent ARIST review on DM defined DM as a multi-
staged process of extracting previously unanticipated knowledge from large databases, and applying 
the results to decision-making within the larger Knowledge Discovery process (Fayyad et al., 
1996). Other authors (e.g., Bellazi and Zupan, 2001) have made the distinction between DM and 
intelligent data analysis (IDA). Similar to Knowledge Discovery in Databases (KDD), IDA 
describes the complete process of data analysis, including pre-processing etc., whereas DM 
describes the actual techniques involved. The relationship between DM and Knowledge Discovery 
in Databases (KDD) has been presented in detail elsewhere (see for example, Adriaans and Zantige, 
1996; Benoit, 2001). Here it is sufficient to state that DM is the knowledge extraction stage of the 
knowledge discovery process which includes the selection of appropriate data possibly from a 
variety of sources, the cleaning of these data, the merging of the data from the different sources, the 
coding and re-coding of the data into an appropriate format, DM itself followed by the presentation 
and reporting of the results of the DM activities. Data mining is therefore a central part of the 
knowledge discovery process and encompasses a range of techniques selected on the basis of their 
suitability for the particular task in hand. The process of DM in health and medical research needs 
to incorporate not only the analyses of data but determining appropriate research questions and 
interpretation of the results (Richards et al. 2001).  
While this portrayal of DM is fairly clear, confusion arises through the use of various synonyms for 
DM as discussed by Benoit (2001) and Trybula (1999). These synonyms include knowledge 
discovery itself, which as indicated above, is the larger process of which DM is but a part. Other 
terms, such as information extraction, pattern discovery and pattern identification are all 
potentially misleading in that they describe either the end product of the process, rather than the 
process itself, or part of the range of ways in which data can be mined. The discovery or 
identification of patterns within data can either be the goal of the DM exercise or can be just a stage 
in a more complex DM process, particularly when used in health and medicine when more precise 
objectives are set.  
Perhaps the most misleading and potentially damaging synonym used for DM is data dredging 
(Benoit, 2001; Trybula, 1999) and in the context of health and medical research a sharp distinction 
must be made between these two processes. In this context, data dredging is used to describe the 
process of analysing a data set to try and uncover interesting relationships between the variables or 
patterns within the dataset. A useful analogy is implicit in the word dredging, which suggests 
laboriously, and perhaps exhaustively, trawling or sifting though something, for example sand or 
mud, in the hope of finding something useful, interesting and/or valuable, e.g., a gold nugget or 
gem. Implicit in this analogy is the idea that person undertaking this activity has no clear a priori 
idea on what they are searching for but if they search for long enough something will emerge. In the 
context of data dredging, the analyst has no specific aim or research question but exhaustively seeks 
relationships and patterns within the data. While it might be argued that the ends of this data 
dredging process, i.e., the identification of a nugget of information, might justify the means the 
problem with this approach is that spurious relationships and patterns can be identified, which arise 
by chance, but which may be attached undue importance (Altman, 1991). For example if a dataset 
containing 20 variables was analysed to try and identify any relationships using traditional 
statistical methods, such as Chi2 tests or Pearson correlation coefficients, then there would be 189 
tests would be carried out. If the commonly used significance level of p 0.05 was used to determine 
whether the null hypotheses should be rejected then by definition 1 in 20, or in this example eight or 
nine test results could appear to be statistically significant, purely by chance. Even if the 
significance level is lowered to p 0.01, then 1 in 100, or in this example 1-2 test results, could 
appear to be statistically significant, purely by chance. Although methods of dealing with such 
chance findings have been reported (Altman, 1991; Bland and Altman, 1995), there is controversy 
concerning the precise use of these adjustments in different situations (Perneger, 1998; Bender and 
Lange, 1999) and data dredging is considered to be inappropriate due to its lack of clear objectives 
and this potential to yield spurious results.  
The phrase DM, on the other hand, presents a different analogy in that it implies drilling down in a 
much more focussed approach with a clear idea of what it is that is being mined for and with a 
reasonable expectation, gained through prior knowledge, of retrieving something worthwhile. Data 
mining suggests that the analyst has a good understanding of the data that they are mining and a 
clear idea, e.g., through their own knowledge of the subject area and/or earlier work, of the 
potentially useful and important information that may be retrieved. It also implies a systematic 
approach to the identification of previously hidden association, patterns and relationships 
(Pendharkar et al., 1999). Using a DM approach might therefore involve identifying a specific 
research question/hypothesis, e.g., through a substantive literature review or a discussion with 
domain experts, and answering/testing this using an existing data source by identifying patterns/ 
relationships/ associations centred round a limited number of variables. Although this does not 
wholly eliminate the risk of identifying patterns/relationships/associations that arise purely by 
chance, nevertheless adopting a focussed approach reduces this risk and is scientifically justifiable. 
The distinction between data dredging and DM must be borne in mind when discussing the use of 
DM in health and medical research and while a data dredging approach can produce unreliable and 
potentially damaging information, especially when used to inform clinical practice and decision-
making. Data mining may therefore be defined by the approach that the researcher is adopting in 
analysing the data as well as by the methods that are used.  
The potential of DM in health and medicine 
In routine health and medical care, large volumes of data are routinely generated and stored either 
as part of the care process, for administrative purposes or for research (Coiera, 1997; Shortliffe and 
Blois, 2001; Pe a-Reyes and Sipper, 200l). The large amount of data and individual data items may 
be of low value in their own right, but there may be valuable information contained within it that is 
not immediately apparent, but which may be extracted and utilised using DM approaches (Kuo et 
al., 2001). This availability of health/medical data and information coupled with the need to 
increase continually our knowledge and understanding of the biological, biochemical, pathological 
and psychosocial and environmental processes by which health and disease are mediated mean that 
the medical and health sector may be particularly suitable for DM (Shortliffe and Blois, 2001; 
Shortliffe and Barnett, 2001).  
Medicine and health deal with complex organisms, i.e., humans and/or patients, and therefore with 
higher-level processes in contrast to other branches of science e.g., physics and chemistry, which 
deal with relatively low-level processes (Shortliffe and Blois, 2001). While some of these higher-
level processes may be reduced to lower levels of complexity in certain application areas, this can 
be inappropriate and unhelpful in clinical medicine and health, and high-level descriptors are 
necessary to try and encapsulate the complexity of humans (Maojo et al., 2002). Therefore while 
traditional computing applications, e.g., routine iterative number crunching using basic numerical 
programs, might be appropriate for the needs of the physical sciences, these are inadequate to deal 
with these complexities and DM techniques have therefore been adopted and developed for this 
purpose (Shortliffe and Blois, 2001). Furthermore, the large and complex search spaces that are 
generated through the data in health and medicine may be beyond the ability of clinicians to make a 
decision that has one of two possible outcomes (Pe a-Reyes and Sipper, 2000). 
While the collection, management, analysis and interpretation of information is a fundamental part 
of the processes of clinical medicine and health care, not least of all in decision-making for the 
categorisation, treatment and management of diseases (Shortliffe and Barnett, 2001), the capture 
and coding of this information for storage in databases and information systems can reduce some of 
its informational complexity and value. However, by analysing and interpreting the encoded data 
either routinely or through DM as part of the knowledge discovery can help gain insights into the 
high level processes that would not otherwise be possible. 
The methodologies that have been developed to help understand the complexity of information that 
are involved in health and medicine (Shortliffe and Blois, 1991; Maojo et al., 2002,), have 
traditionally been based on hypothetico-deductive reasoning (Lisboa, 2002), the inference of causal 
relationships (Altman, 1991; Bland, 2000) and the recognition of patterns and development of 
heuristics among others. Health and medicine research involve the development and testing of 
theories that involve the human being and its components that cannot be changed (Maojo et al., 
2002). Added to this is the current tension within the practice of modern clinical medicine practice 
and healthcare between the need for a suitable evidence base which implies that the complex 
processes outlined above can be adequately measured and quantified (positivism) and the more 
recent post-positivistic realisation that this information can only be truly informative when coupled 
with more qualitative information and analyses.  
As health and medicine have become more data and information-intensive the amount and variety 
of information collected and stored has increased (Richards et al., 2001), and this information has 
become more accessible through the increasing use of computers in the healthcare process (van 
Bemmel and Musen, 1997). Traditional methods of analysing data may not be adequate to deal with 
the large volumes of data and to maximise the potential for secondary analyses of these data. 
Traditional epidemiological approaches to investigating rates and causes of diseases at a population 
level (Friedman, 1994), have used descriptive statistics to measure disease and inferential statistics 
to test hypotheses by investigating the extent to which the variance of a given disease occurrence 
can be explained by variables of interest (potential risk factors) relative to other often unexplained, 
and labelled random, variance (Giuliani and Benigni, 2000). Although such studies work well when 
there is a single causative agent far exceeding all the others (Giuliani and Benigni, 2000, p.308) 
many diseases and conditions, particularly non-infectious diseases, may have multiple causative 
agents or have many risk factors, and the traditional epidemiological and statistical approaches 
struggle to discriminate between a range of putative risk factor or causative agents and the random 
variance. In other words the signal to noise ratio is too low to be able to elucidate causes 
effectively (Giuliani and Benigni, 2000). Although proponents have discussed the potential of DM 
to overcome these limitations, there remains much scepticism among medical statisticians 
concerning the real value offered by such methods (Schwarzer et al., 2000). In addition, the low 
signal to noise ratio that is common in health and medical data means that the potential advantages 
of flexible non-linear DM tools compared to statistical techniques will not be realised. However this 
may be overcome as advances in understanding of risk factors for disease and health outcomes 
improves the potential for diagnostic and prognostic models (Biganzoli et al., 2002). In order to 
appreciate the potential of DM approaches to analysing health and medical information, traditional 
inferential statistical methods will be briefly discussed together with their limitations. 
Traditional statistical methods for analysing such data and their limitations. 
Traditional methods of analysing health and medical data have been developed within a positivist 
paradigm, in which hypothetico-deductive methods to set up null hypotheses have been proposed 
which are then tested using inferential statistical techniques based on parametric and non-
parametric tests, such as t-tests, Chi2-tests, correlation and regression (Altman, 1991; Bland 2001). 
Although inferential statistical methods have long been accepted for use in science, health and 
medicine, they have their limitations and although they provide a measure of statistical significance, 
this does necessarily indicate their clinical importance (Last et al., 1999).   
While some of these tests, e.g., t-tests, Chi2-tests and correlation involve univariate or bivariate 
analyses and DM techniques offer little above and beyond these, other forms of analyses such as 
cluster analysis and regression can involve greater numbers of variables with complex interactions, 
which DM tools have the potential to augment. Linear regression is used widely in health and 
medical research to identify the association between one (simple linear regression) or more 
(multiple linear regression) independent, or predictor, variables and a continuous dependent, or 
outcome, variable, and to predict the value of the outcomes variable for a given value of a predictor 
variable (Altman, 1991; Bland, 2000). Linear regression is useful in that it is relatively 
straightforward and uses a single coefficient within the regression model to summarise the 
contribution of each predictor variable (Dusseldorp and Meulman, 2001). Adaptations of linear 
regression have been made to permit binary outcome variables to be used as the dependent variable 
(simple logistic regression) and nominal variables (multinomial logistic regression) through a 
transformation of the dependent variable (Altman, 1991). Rather than being used to predict the 
value of the outcome variable for a given value of a predictor variable, logistic regression uses the 
coefficient to calculate the odds, termed the odds ratio, of the category of interest occurring, for 
each category of an independent categorical variable relative to a selected reference category, or for 
each increment in the magnitude of an independent continuous variable. Logistic regression is 
particularly useful in health and medical research as many outcomes of interest occur, or can be 
represented, as binary variables, e.g., the presence or absence of disease, being alive or dead, a 
response to treatment or not, disease recurrence, etc., (Altman, 1991). Logistic regression can also 
be useful in making predictions and has therefore been widely used for assisting in clinical 
decision-making for diagnosis and prognosis.  
Survival analysis is a term used to describe studies in health and medicine that account for any 
event (i.e., not just mortality per se) occurring over a period of time within a population or group of 
interest (Altman, 1991). The statistical methods of analysing survival are based upon comparing the 
distribution of survival times of different groups of patients or on the development of appropriate 
regression models (e.g., logistic regression and Cox regression) to analyse the effects of variables 
on survival (Anand et al., 1999). Parametric models for survival analysis have proved inadequate to 
deal with the complex relationships between predictor variables and events of interests due to their 
assumptions on failure time distributions and the effects of the covariates on these distributions 
(Biganzoli et al., 2002). The development of semi-parametric method has overcome these 
limitations but only allows the identification of putative risk factors. Another important issue in 
developing methods for analysing survival in the context of health and medicine is in ensuring that 
models deal adequately with right-censored data, i.e., although models may able to analyse the time 
to an event happening they need to be able to differentiate between the event happening and it not 
happening within a given time period of analysis. For example, all the patients undergoing different 
treatments for cancer may not die within 21 months, or some of the patients who have had one 
myocardial infarction may never experience another. Although logistic regression is useful in 
medicine and health for analysing disease risk and predicting outcomes, it fails to consider the time 
at which an event occurs (Altman, 1991; Bland 2000), and this information is can be particularly 
important in determining the importance of putative risk factors for events of interest. The Cox 
proportional hazards regression model (Cox, 1972), often termed Cox regression, accounts not only 
for whether an event has occurred or not, but the length of time which it took that event to occur, or, 
if the event does not happen, to a point of censorship. Analysing survival for diseases and 
conditions plays an important role in clinical medicine to enable health care professionals to 
develop prognostic indices for people following diagnosis, either for mortality in potentially 
terminal illnesses, recurrence of the disease, studying outcomes for different forms of treatment or 
for assessing the risk of adverse health events occurring.  
Traditional statistical methods are not able to deal satisfactorily with some problems associated with 
data generated through clinical practice and medical/health research. The nature of relationships 
between variables is complex and multivariate (Biganzoli et al., 2002), and there are often 
interactions among the predictor variables and assessing these and their effect on the outcome 
variable can be complex (Dusseldorp and Meulman, 2001). In addition, the preponderance of non-
linear relationships among health and medical data and the non-additive effects of multivariate 
relationships between predictor variables and outcome variables (Biganzoli et al., 2002) violate 
assumptions of linearity implicit in inferential statistical models and make them potentially suitable 
for other DM tools.  
Logistic and Cox regression are important in generating population-based estimates of survival, for 
identifying putative risk factors and logistic regression can be used to test the effectiveness of 
putative diagnostic and prognostic tools using a classification table that makes predictions on the 
basis of the values for the predictor variables for each case (this is explained below in relation to 
Table 1). It is then possible to evaluate these models by comparing the result with the actual 
outcome or diagnosis (Altman, 1991; Bland 2000). However, they are not used for making 
predictions concerning individual patients in a clinical setting (Anand et al., 1999; Botacci et al., 
1997), and health care professionals tend to rely on their own knowledge, experience and 
judgement, which have their limitations and are prone to human error. 
Decision-making by health care professionals is based on knowledge gained through initial training, 
updating this through continuing professional development and personal learning, and also by 
development of own experience (Brause, 2002). Early in their careers health care professionals have 
limited experience, which is particularly important for relatively new diseases/conditions or ones 
that are rare in occurrence. Health care professionals and managers are humans, who are better at 
pattern recognition tasks then basing decisions for example on statistical probabilities (Brause, 
2002; Lisboa, 2002, Walker et al., 1999). Although some of these problems may be overcome, e.g., 
by consulting with more-experienced/ knowledgeable colleagues, decision-making, e.g., in 
diagnosis, may be flawed by lack of available experience with the particular condition or their 
ability to deal with complex data. Data mining may help overcome these problems, e.g., by 
identifying patterns that were not previously apparent, or by learning from data to make decisions, 
predictions, or prognoses and diagnoses (Downs et al., 1996). 
In order to assess the suitability of traditional statistical methods of analysing data and to compare 
these with the performance of DM methods, appropriate means of evaluating the performance of 
diagnostic, prognostic and other data analytic tools. 
Evaluation of methods 
In order to assess the value of any data-mining tool for use in routine clinical practice, it is 
important to be able to evaluate its effectiveness, and compare that with other methods of analysis. 
For example, the correct diagnosis of diseases and being able to make an accurate prognosis is vital 
for managing the overall care of a patient. When developing and evaluating new methods of 
diagnosing conditions and making prognoses, it is necessary to compare the predicted value with 
the true diagnosis, or with the eventual outcome or prognosis. The predicted diagnosis or predicted 
prognosis can be compared with the true diagnosis and eventual outcomes respectively using a 
classification table as shown in table 1 (Altman and Bland, 1994a). 
 True diagnosis  
Diagnosis by new method Negative Positive Total 
Negative a b a+b 
Positive c d c+d 
Total a+c b+d a+b+c+d 
Table 1: Table to compare the results of the true diagnosis with the results from the 
prediction. 
It can be seen from that the true diagnosis showed that n= a+c individuals or cases were diagnosed 
as not having the condition, and of these the new method correctly diagnosed n= a as not having the 
condition (called true negatives). The true diagnosis showed that n= b+d individuals or cases were 
diagnosed as having the condition, and of these the new method correctly diagnosed n= d as having 
the condition (true positives). Overall the new method was correct for n= a+d individuals. 
Conversely, the new method incorrectly diagnosed n= b individuals as not having the condition 
(false negatives) and it incorrectly diagnosed n= c individuals as having the condition (false 
positives) (Lavra , 1999b, Altman and Bland, 1994a). 
Sensitivity, sometimes called recall in information retrieval, is the measure of how many of the 
individuals with the condition that the test detects, in other words the proportion or percentage of 
true positives (Altman and Bland, 1994a). This is calculated by [sensitivity = d /(b+d)] and is 
expressed as either a decimal or a percentage (multiplied by 100). Sensitivity is important in 
assessing how good the method is at identifying the individuals that have the condition. If the test 
were used in routine practice then these people will potentially benefit from any intervention, e.g., 
medication or treatment, given to people whom the test identifies. Specificity (sometimes called 
precision in information retrieval), on the other hand, is a measure of how many of the individuals 
without the condition that the test detects as not having the condition, i.e., the rate of detecting true 
negatives, and is calculated by [specificity = a /(a+c)], (multiplied by 100) if expressed as a 
percentage. Two further measures for evaluating a method of diagnosis are the positive and 
negative predictive values (Altman and Bland, 1994b). The positive predictive value (ppv) is the 
proportion (or percentage) of individuals that the method diagnoses as having the condition that 
actually have the condition, and is calculated by [Positive predictive value = d /(c+d)],  100. 
Conversely, negative predictive value (npv) is the proportion (percentage) of individuals that the 
method diagnoses as not having the condition that actually do not have the condition, and is 
calculated by [Negative predictive value= a /(a+b)] (  100). The final estimate of accuracy is the 
Receiver Operating Characteristic curve, which plots sensitivity against (1  specificity) after 
calculating the sensitivity and specificity of every observed datum  (Altman and Bland, 1994c). 
Although by enabling the comparison of sensitivity and specificity in a single graph, this plot gives 
one of the best estimates of the effectiveness of a procedure, additional calculations need to be 
incorporated to ensure that the prevalence of the condition in the population is taken into account 
(Bland and Altman, 1994c; Jefferson et al., 1995; MacNamee et al., 2002). Many DM methods are 
aimed at developing improved methods for making decisions, especially for diagnosis or prognosis, 
and evaluating the outcomes in terms of these values of sensitivity, specificity, positive and 
negative predictive values in this specialised area of DM will be discussed. The relative importance 
of these measures of effectiveness within a particular clinical or health context has an important 
impact on the development of tools and will be discussed in more detail later. 
Data mining tools for health and medicine. 
Data mining tools generally one of two forms of learning (supervised or unsupervised) for 
classification, making predictions and other DM activities (Pe a-Reyes and Sipper, 2000). 
Supervised learning is used when an DM tools is trained to recognise different classes of data by 
exposing the network to a series of examples for which it has target answers (the training data set), 
and then testing how well it has learned from these examples by supplying it with a previously 
unseen set of data which it then classifies (the test data set). Unsupervised learning, on the other 
hand, requires no initial information regarding the correct classification of the data with which it is 
presented to partition data.  
Recent reviews by Lavra  (1999a, 1999b) have described and discussed different methods of 
machine learning available for DM in health and medical research. Machine-learning methods 
include three main types of DM tool including the inductive symbolic rule learning, statistical or 
pattern recognition methods, and artificial neural networks (Lavra , 1999a). All of these techniques 
seek to improve medical diagnosis and prognosis by analysing data from previous patients, defined 
as a training set, and from this learning process to predict the diagnosis and/ or prognosis for new 
groups of patients, the test set. Lavra  (1999b) categorised DM methods into those methods that 
produce symbolic representations from the data they are analysing and include rule induction 
methods, decision trees and logic programs and those that produce a sub-symbolic representation, 
which include instance-based learning methods such as nearest neighbour algorithms, artificial 
neural networks and Bayesian classifiers. A key distinction between symbolic and non-symbolic 
methods is the relative transparency (or white box) of decision-making using symbolic methods 
compared with the black box approaches of non-symbolic methods (Liebowitz, 2001b). 
Inductive learning of symbolic rules 
Inductive learning of symbolic rules, e.g., rule induction algorithms, decision tree algorithms and 
logic programs, create symbolic if-then rules from the training set that are used to generalise and 
which are then applied to the classifying the test set of patients (Lavra , 1999a). The symbolic rules 
are of the form  
IF Condition(s) THEN Conclusion  
Or 
Condition(s)  Conclusion 
in which the Condition(s) part includes one or more tests for values of the variables (labelled 
attributes, Ai, that are being included in which attribute tests such as Ai = value for discrete 
(categorical) variables and Ai < value and/or Ai < value for continuous variables. The Conclusion 
part assigns a value to a class of predictions, Ci (Lavra , 1999b). Although rules derived through 
this process imply an association between the condition and the conclusion, Richards et al. (2001, 
p.216) point out that there is no implication of cause and effect between the two. 
Rule-based approaches have been used in a number of areas in health and medicine including the 
diagnosis of rheumatic diseases, prognosis following cardiac tests (cited in Lavra , 1999a), the 
prediction of early mortality in relation to first hospital visits (Richards et al., 2001) and in 
analysing meningitis data (Zhong and Dong, 2002).  
Decision trees 
Decision trees, also called tree-based methods, are a very popular type of DM technique and are 
based on a method called recursive partitioning, that has been used for solving regression and 
classification problems in health and medical research (Dusseldorp and Meulman, 2001; Kuo et al., 
2001). Regression trees are used to model continuous outcome variables to predict specific values 
for a variable of interest and classification trees are used to model categorical variables in order to 
predict to which group an individual or case belongs (Dusseldorp and Meulman, 2001; Kuo et al., 
2001). The decision tree model can be used for descriptive purposes as well as for making 
predictions (Kuo et al., 2001; Ennis et al., 1998). The model is presented in the shape of a tree with 
branches and leaves with decision rules on how the tree was constructed. Kuo et al. (2001) used a 
decision tree model to code breast cancer tumours as malignant or benign and showed that the 
overall accuracy of the decision tree model was better than that of the physician, as well as the 
sensitivity, specificity, positive and negative predictive values. Recursive partitioning has been 
shown to be of value in identifying interactions among variables (Carmelli et al., 1991). Carmelli et 
al. (1991) compared the use of recursive partitioning with Cox regression for examining the 
relationship between baseline biological and behavioural characteristics and mortality due to 
coronary heat disease and cancer over 27 years. Although both Cox regression and recursive 
partitioning were useful in determining factors associated with mortality, recursive partitioning 
enabled the identification of subgroups of individuals with particular characteristics and survival 
features (Carmelli et al., 1991).  
Artificial Neural Networks. 
Although the original research into ANNs started in the 1950s it is only relatively recently that they 
have emerged as a useful and effective set of tools for tackling a range of DM problems, including 
pattern recognition, prediction of outcomes, classification and partitioning of multivariate data 
(Haykin, 1999; Bath and Philp, 1998). They have been applied in a variety of domains (Dayhoff, 
1990; Trybula 1999; Benoit 2001), including health and medicine (Cross et al., 1995; Baxt, 1995; 
Dybowski and Gant, 1995; Brause, 2002). ANNs are so-called because they have structures and 
processes that are modelled on the architecture and learning processes in biological nervous 
systems. ANNs have the potential to extract information that is complementary, rather than an 
alternative, to that obtained using statistical methods. ANNS differ from such methods in being 
adaptive, i.e., the data are presented to the ANN iteratively, during which the network learns and 
then revises the predictions or classifications it has made.  During these iterations the network is 
trained and is able to recognise patterns in the data and as a result of the training the ANN can 
make predictions or classifications (Lipmann, 1987).  
ANNs use both supervised and unsupervised learning to mine data. ANNs employing unsupervised 
learning, e.g., Kohonen self-organising maps, are able to analyse multi-dimensional data sets in 
order to discover the natural patterns, or clusters and sub-clusters, that exist within the data 
(Lipmann, 1987; Kohonen, 1995). ANNs using this technique are able to identify their own 
classification schemes based upon the structure of the data provided. Unsupervised pattern 
recognition is similar to traditional methods of cluster analysis and is based on measures of 
similarity. ANNs using supervised learning, e.g., multi-layer perceptrons and radial basis function 
networks, learn from a training data set and then use a test data set to make predictions or 
classifications based on this learning. Supervised learning is more commonly used in modelling 
data derived from health and medicine (Lavra , 1999b). 
Artificial neural networks have been used in a wide variety of applications in clinical medicine, 
including diagnosis, risk assessment, analysing medical images and wave forms, treatment selection 
and predicting outcomes and drug activities and responses to medication in clinical pharmacology 
(cited in and in Lavra , 1999b). Artificial neural networks have been used for diagnosing a wide 
range of health and medical problems including myocardial infarction (heart attack) (Baxt, 1991; 
Baxt and Skora, 1995; Ennis et al., 1998), different forms of cancer (Pendharkar et al., 1999), 
detecting ischemia (Papaloukas et al., 2002), appendicitis, back pain, dementia, psychiatric 
emergencies, pulmonary embolism, sexually transmitted diseases, skin diseases and temporal 
ateritis (cited in Baxt, 1995). Improved methods of diagnosis for myocardial infarction are 
necessary because although the disease incidence is low, the consequences of a myocardial 
infarction not being diagnosed are very serious and potentially fatal (Baxt, 1995). Clinicians 
therefore tend to diagnose to avoid the risk of missing diagnosis of myocardial infarction and 
although they may have a high sensitivity, the specificity of their diagnoses is relatively low and 
results in unnecessary hospital admissions. Baxt (1995) identified a number of conditions, including 
recovery from surgery for which artificial neural networks had been used in prognosis, to predict 
outcomes following surgery in intensive care units and orthopaedic rehabilitation units (Grigsby et 
al., 1994), recovery from prostate, breast and ovarian cancer (Downs et al., 1996), cardiopulmonary 
resuscitation and liver transplantation (Doyle et al., 1994) and rehospitalization following stroke 
(Ottenbacher et al., 2001). Neural networks have also been used extensively for analysing survival 
data (Biganzoli et al., 1998; Biganzoli et al., 2002; Cacciafesta et al., 2001; Cross et al., 1995; 
Downs et al., 1996) and for predicting outcomes for providing policy information in the 
management of hypertension (Chae et al., 2001).  
ANNs have a number of advantages over statistical techniques that make them particularly suitable 
for mining health and medical data. ANNs are non-parametric and therefore do not make 
assumptions about the underlying distributions of the data that statistical methods make (Lippmann, 
1987). ANNs therefore may be more robust and perform better when data are not normally 
distributed or where there is a non-linear relationship between predictor variables and an outcome 
variable. Artificial neural networks are able to analyse the higherorder relationships frequently 
present in health and medical data that traditional statistical tools are less capable of dealing with 
(Cross et al., 1995). However, the black box nature of ANNs, in which data are fed in and results 
are obtained but with very little understanding of the reasons for the decision (Tu, 1996), is one of 
the fundamental limitations and why their use has been regarded with suspicion and mistrust within 
the medical and statistical communities. Downs et al. (1996, p.411) discussed the need to 
supplement using neural networks with the extraction of symbolic rules to provide explanatory 
facilities for the networks reasoning and developed symbolic rules to try and explain the 
reasoning behind the decision-making by the neural network, and a number of techniques have been 
developed which permit this (Andrews et al., 1995). 
A further problem with ANNs is that their performance on test data set is often worse than that 
achieved through the training set (Brause, 2002) due to the network over-training and adapting to 
any biases in the training set. Although on solution to this is to use a training data set that is 
representative of the test set, e.g., by randomly allocating training and test data from an original 
data set and checking that there are no significant differences between training and test data sets. 
However the training and test data are not then independent of each other and subtle differences 
between training and test data sets may lead to a deterioration in performance, or when the network 
is used on truly independent data set, e.g., in clinical environment (Brause, 2002). Cross et al. 
(1995) commented that on the less rigorous development of artificial neural networks compared to 
that for conventional statistical tests and that large scale clinical trials may be needed to evaluate 
their use statistically before they are accepted as a diagnostic tool. Further limitations of DM tools 
will be discussed later. 
Evolutionary DM tools  
As the name implies evolutionary DM tools encompass those computational techniques that are 
based on the principles and processes of evolution in nature, particularly those of reproduction, 
mutation and selection (Goldberg, 1998; Pe a-Reyes and Sipper, 2000). Evolutionary tools are 
methods of searching through the high dimensional space of possible solutions to a given problem 
to find an optimal solution and are particularly suited to use in DM in health and medicine given the 
preponderance of variables and multivariate relationships discussed previously. 
Evolution is the theory of how living organisms developed over million of years from more 
primitive life forms. The manifestation of each individual (i.e., its phenotype) within a population is 
determined ultimately by its genetic make-up or genome (genotype), which is encoded on 
chromosomes via genes. This genetic information is unique to each individual and reproduction, the 
process by which new individuals are created, involves the development of a new genome for that 
individual. Reproduction may be asexual in which only one individual of a species is involved, or 
sexual in which two members of the species are involved. Sexual reproduction involves the 
development of an entirely new genotype by recombination of the genetic material of the parents. 
This process is supplemented by mutation in which small changes to the genetic material are 
introduced at random. The offspring from sexual reproduction then undergo the process of selection 
in which the Darwinian survival of the fittest occurs, so that those individuals that are best suited 
to the environment survive long enough to reproduce and pass their genetic material to the 
following generation. Over many generations success in this process will permit the adaptation of 
the species to ensure its survival within the environment.  
In evolutionary computing the environment represents the problem situation of interest, and the 
individuals within the population in this environment represent possible solutions to this problem 
(Goldberg, 1989). The algorithms for the various types of evolutionary computing tools are based 
on a common procedure in which the initial population is generated randomly or using heuristics 
(Pe a-Reyes and Sipper, 2000). The features or attributes of each individual are encoded via genes 
on a chromosome and associated with each chromosome is a fitness function, which measures its 
suitability to the environment or problem situation. The population then undergoes a series of 
generations in which individuals (chromosomes) within the population undergo sexual reproduction 
to create new individuals (chromosomes) with new genotypes containing genetic material from the 
parents cross-over to create new genotypes, which are also subject to mutation. The offspring from 
this process then join the population and each has fitness function associated with its genotype. The 
fitness of each individual is determined by decoding and evaluating the genotype according to 
predefined criteria dependent on the problem being addressed. The strength of this fitness function 
will determine whether the individual survives to reproduce and pass on its genetic material to the 
next generation: individuals (chromosomes) having the highest fitness functions will form a mating 
pool form the next generation and the individuals (chromosomes) having lower fitness functions 
will be lost from the population. This selection process ensures that the fittest individuals pass their 
genes to the next generation. The cross-over ensures that new combinations of genetic material are 
introduced and move towards promising new areas of the search space (Pe a-Reyes and Sipper, 
2000, p.23). Mutation prevents the process from converging in local optima that do not represent 
optimal solutions and the new individuals then enter the environment and the next generation 
commences. Thus, similar to natural evolution, over time and a number of generations, the 
population should adapt to the environment and a good approximation to an optimal solution to the 
problem should emerge. The process is terminated after a specified number of generations or when 
a predefined level of fitness is achieved.  
One of the advantages of evolutionary computational tools over more traditional search methods is 
that they are able to combine a search of all the available search space with the capacity to search 
the most promising areas (Pe a-Reyes and Sipper, 2000). The results of the searches in these spaces 
can then be combined via cross-over in reproduction and new areas of the search space can be 
investigated through mutations. This combination of targeted and stochastic search techniques 
means that evolutionary tools require less knowledge on the search space and make fewer 
assumptions about it (Pe a-Reyes and Sipper, 2000). The key considerations when using 
evolutionary DM tools include not only how to encode the features of possible solutions into genes 
but also how to measure the fitness of the individuals and chromosomes. These two issues are 
dependent on the specific problem and have to be tailored to the particular needs of that problem 
(Pe a-Reyes and Sipper, 2000), and although the processes of selection, cross-over and mutation 
are relatively problem-independent, it is likely that these issues will need to be considered in 
adapting tools to particular problems. 
Genetic algorithms 
Several different types of evolutionary DM tools exist although the there is a deal of similarity 
among these types and they are all based on the principles and process of evolution. The most 
commonlyused type of evolutionary tools are genetic algorithms, which represent the genome 
(genotype) of the individual (phenotype) using a fixed-length binary string (Pe a-Reyes and Sipper, 
2000). Although genetic algorithms can be used to generate solutions to almost any problem if the 
genotype can be represented in this way, care must be taken to ensure that no two genotypes encode 
the same phenotype (termed redundancy), in order to achieve a good solution (Pe a-Reyes and 
Sipper, 2000). Using genetic algorithms, the number of individuals (population) is kept constant 
and during each generation these are decoded and their fitness is evaluated and the fittest are 
selected for reproduction. 
Genetic algorithms have been used for analysing sleep patterns (Baumgart-Schmitt et al., 1998), 
diagnosis of female urinary incontinence and breast cancer (cited in Pe a-Reyes and Sipper, 2000), 
development of prognostic systems for colorectal cancer (Anand et al., 1999), selection of features 
for recognizing skin tumors (Handels et al., 1999), prediction of depression after mania (Jefferson et 
al., 1998b), predicting outcomes after surgery, predicting survival after lung cancer (Jefferson et al., 
1998a), improving response to warfarin (Naranyan and Lucas, 1993), survival after skin cancer and 
estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma (cited 
in Pe a-Reyes and Sipper, 2000). 
Genetic programming and other evolutionary methods 
Work by Koza (1990a and b) developed and extended the idea of evolutionary computational tools 
such as genetic algorithms by using genetic programming. While the basic evolutionary principles 
of genetic algorithms and genetic programming are similar, the features by which these tools carry 
out their tasks are fundamentally different and are discussed by Pe a-Reyes and Sipper (2000). 
Genetic programming encodes possible solutions to problems as computer programs rather than as 
binary strings and to achieve this they use parse trees and functional programming languages, 
unlike genetic algorithms, which use line code and procedural languages. Genetic programming 
allows both asexual reproduction, in which the individuals with the highest fitness survive intact to 
the succeeding generation, as well as sexual reproduction, in which randomly-selected points in the 
parse trees are selected and the subtrees beneath these points are exchanged between the parents 
(Pe a-Reyes and Sipper, 2000). Genetic programming tools have been less widely adopted as a 
data-mining tool in health and medical research than genetic algorithms but have been used to 
identify causal relationships in a database containing information on children with limb fractures 
and to identify relationships in a database containing information on spinal deformation (Ngan et 
al., 1999), to classify brain tumours into meningioma and non-meningioma classes (Gray et al., 
1998), learning rules from a fractures data base (Wong et al., 2000) and for the diagnosis of chest 
pain (Bojarczuk et al., 2000).  
Evolution strategies and evolution programming, two other methods of evolutionary computation, 
have had some relatively little use in mining health and medical data and are described by Pe a-
Reyes and Sipper (2000). Their use has been restricted to for analysing sleep patterns (Baumgart-
Schmitt et al., 1998), detecting breast cancer using histologic data (Fogel et al., 1995) and 
radiographic features (Fogel et al., 1997) and optimising electrical parameters for therapeutic 
stimulation of the carotid sinus nerves (Peters et al., 1989).  
Combined approaches 
Evolutionary computing techniques have been used in combination with other tools for mining 
health and medical data. Genetic algorithms have been combined with several statistical and non-
statistical methods as a way of optimising the variables for inclusion in models. Several groups of 
researchers have combined genetic algorithms with neural networks for detecting and diagnosing 
breast cancer (Abbass, 2002; Fogel et al., 1995), predicting response to warfarin (Naranyan and 
Lucas, 1997), predicting outcomes following surgery (Jefferson et al., 1997), predicting 
haemorrhagic blood loss (Jefferson et al., 1998a), predicting depression following mania (Jefferson 
et al., 1998b) and for predicting falls and identifying risk factors for falls in older people (Bath et 
al., 2000). Fogel et al. (1995) used evolutionary artificial neural networks for analysing histological 
data to detect and diagnose breast cancer. Fogel et al. (1997) used evolutionary programming to 
train artificial neural networks to detect breast cancer using data from radiographic features and 
patient age. One of the problems in the use of artificial neural networks is that they can get stuck in 
local optima, and although increasing number of nodes and weights associated with them can help 
overcome this problem this is computationally more intensive. Combining GAs with Artificial 
Neural Networks can help the network overcome local optima and improve the topology of the 
neural network (Fogel et al., 1997). Genetic algorithms have been used in combination with 
Bayesian networks to predict survival following malignant skin melanoma (Sierra and Larrañaga, 
1998). Ngan et al. (1999) also used genetic programming in combination with Bayesian networks to 
identify rules for limb fracture patterns and for classifying and treating scoliosis. Holmes et al. 
(2000) combined a genetic algorithm with a rule-based system for epidemiologic surveillance. 
Pe a-Reyes and Sipper (1999) combined genetic algorithms with a fuzzy system for the diagnosis 
of breast cancer. Although these studies represent attempts to combine evolutionary computing 
techniques with DM tools there has been little work combining evolutionary computing methods 
with statistical methods to optimise the variables used in predictive models (Jefferson, 2001) and 
there is potential for further work in this area. 
Application of DM tools in diagnosis and prognosis 
Data mining tools have been used for a range of tasks, but have been particularly used for diagnosis 
and prognosis of diseases and, in this section, their application in the diagnosis of breast cancer and 
for prognosis are discussed.  
Breast cancer is one disease that has attracted a deal of interest from data miners, particularly in 
relation to diagnosis. Reasons for this include its high incidence and relatively high mortality 
associated with it, the importance of early diagnosis, and, as Abbass (2002, p.265) suggests, 
because of the very high economic and social values associated with it. Problems with the 
traditional assessment of mammographic data have included inconsistencies in interpretation 
resulting in poor intra- and inter-observer disagreement (Abbass, 2002; Fogel et al., 1997). The 
proposed reasons for this have been poor image quality of mammographic images and human 
fatigue and error, and have led to the development of search for pattern recognition techniques to 
supplement the diagnosis by the radiologist (Fogel et al., 1997). The aim of such developments has 
been to reduce the rate of false negative diagnoses to improve the sensitivity. However, given the 
cytotoxic side effects of chemotherapy and radiotherapy and psychosocial consequences of breast 
surgery it is also important to ensure that the number of false positive diagnoses is minimised, i.e., 
and a high positive predictive value is achieved. Additional potential benefits of developing and 
using automated techniques and procedures include lower costs for handling mammograms and 
freeing up the time of the radiologist and improving overall efficiency and effectiveness (Fogel et 
al., 1997).  
Wu et al. (1993) reported artificial neural networks that were better at analysing mammographic 
data than radiologists for decision-making in relation to the diagnosis of breast cancer. However 
these data had been extracted by radiologists, and the authors recommended that the real potential 
of neural networks was to assist the radiologists in recommending further tests to be undertaken. 
Setiono (1996, 2000) developed an accurate neural network program that was used pruning to 
extract rules to provide information on the basis on which the network had made its decisions and 
overcome the black box element of neural networks. Many of the cited studies used the same 
Wisconsin Breast Cancer data set for developing the models. While this is useful for comparing the 
effectiveness of different tools developed at different times, it emphasises the need to test DM tools 
on new sets of data in different settings, in addition to the ones in which they were developed 
(Lisboa, 2002).  
Walker et al. (1999) described the use growing cell structure technique to differentiate between 
benign and malignant breast tumours. This technique, which was shown to have a similar 
performance to logistic regression, allows the multidimensional data (the predictor variables) to be 
viewed as two-dimensional colour images. The particular value of the this visualisation was that it 
permits health care professionals to perceive relations between the predictor and outcome variables, 
as well as interactions among the predictor variables (Walker et al., 1999).  
Prognosis has already been highlighted as an important area for patient care and the limitations of 
both parametric and non-parametric statistical methods have led to the development of techniques 
that combine traditional survival analysis methods with artificial neural networks (Anand et al., 
1999; Cacciafesta et al., 2001; Liestol et al. 1994); Faraggi and Simon, 1995; Xiang et al., 2000; 
Zupan et al., 1999). Although some studies have shown that data mining methods perform better 
than statistical models for analysing survival (Anand et al., 1999; Zupan et al., 1999), the study by 
Anand et al. (1999) showed that none of the three DM tools was able to handle the censored data as 
well as Cox regression dealt with them. 
The validity of prognostic models should be tested on a sample that is independent from the training 
sample with respect to time and place and patients in the sample (Wyatt and Altman, 1995). 
However, DM techniques are often developed, trained and tested on sets that are drawn from the 
same sample of patients and are not therefore truly independent of each other (Richards et al., 
2001). The models cannot be regarded as having been independently tested, but require further 
testing on an independent set of data. Wyatt and Altman (1995) also reported that all clinically 
relevant data should be included in any prognostic model that is developed. However defining the 
data which are clinically relevant for a particular condition is not necessarily a simple task and 
prognostic models are often developed through the secondary analyses of data that were collected 
for an entirely different purpose, and it may not therefore have been practical or feasible to include 
all clinically relevant data in the model (Richards et al., 2001).  
In many diseases a wide variety of clinical variables influence the prognosis for a disease and an 
individual, and making predictions for individual patients remains problematic, but is particularly 
important among patients diagnosed with a potentially terminal illness. Although it is known that 
approximately x% of patients survive at least y years following treatment for a particular cancer, 
such population-based estimates are of limited value in supporting and treating individual patients, 
many of whom may want to know How long will I live?, especially as the deviation from the 
mean varies greatly among such patients (Bottaci et al., 1997). Anand et al. (1999) highlighted the 
need for better tools for prognosis of the disease especially in those patients with potentially 
terminal diseases, in which palliation and maintaining quality of life may become the main 
objective. Information on the likelihood of survival and expected life expectancy can greatly assist 
in improving the quality of life of such patients by providing appropriate counselling and disease 
management (Anand et al., 1999).  
Challenges for DM in health and medicine.  
Having described a number of DM tools and discussed their application in the domain of health and 
medicine the challenges that such tools face will be discussed together and suggestions of how these 
may be tackled. Mistrust and suspicion of DM tools can be overcome to some extent by 
acknowledging and presenting clearly the limitations of DM tools and avoiding exaggeration of 
their potential and a number of authors have made recommendations for the development of DM 
models and decision support tools based on DM tools in order that they may gain wider acceptance 
(Kononenko et al., 1998; Lisboa, 2002).  
At one level there are a number of technical challenges that DM tools have to addressed in order 
to gain wider acceptance among health and medical professionals and statisticians (Lisboa, 2002) 
and at another level, there are more human challenges that need to be addressed. Some of these 
more technical issues, such as the appropriate design of studies that develop and test DM tools and 
the need to represent data in an appropriate format (Isken et al., 2002) and to ensure that the data are 
of a high quality (e.g., in relation to missing data, consistency of data collection and recording), are 
common to statistical and DM methods. The statistical aspects of underlying data and models may 
not being given appropriate consideration (Biganzoli et al., 2002) and it is important that descriptive 
statistics are available of data that are being mined as well as data that are being tested statistically. 
While many studies in health and medicine have made use of descriptive and inferential statistics 
without the apparent need for data mining tools, data mining tools cannot be developed in isolation 
of traditional statistical methods. 
Lisboa (2002) discussed the need to clarify the purpose of studies and to specify in advance what is 
expected to be of value in future studies. Data mining tools being used are not necessarily the most 
advanced available or it can be difficult to determine that the chosen model is the best possible (Tu, 
1996). The performance of DM tools could be enhanced by using more advanced types of genetic 
algorithms, artificial neural networks, etc. (Anand et al., 1999). 
Data may be collected for a purpose other than that for which they are being analysed and therefore 
not clinically relevant for the diagnosis or prognosis for which they are being used (Richards et al., 
2001, Wyatt and Altman, 1995). Missing data are particularly a problem in medical databases and 
often arise through incomplete data being recorded or human error in recording/ transcription 
(Richards et al., 2001; Brause, 2002). Missing data can be dealt with by removing variables and/or 
cases that have a high proportion of missing values to minimise the amount of missing data, 
although this approach may introduce bias to the remaining data because cases (individuals) with 
large amounts of missing data may not be representative of the sample have particular associations 
with the outcome of interest. Replacing missing data with statistical descriptors, e.g., the mean 
value for a variable, is generally acceptable if done with care, but may introduce bias to the data 
(Altman, 1991). 
Ensuring that other forms of bias are not allowed to influence the results when developing and 
testing DM tools is important and concealing the correct classification from domain experts until 
the studies are completed so that the DM methods can be truly acknowledged responsible for the 
associations that were discovered and reported (Richards et al., 2001). However, the main objective 
of such studies should be to develop models that are clinically useful and of potential benefit to 
patients, so that once models and tools have been validated then combining the domain knowledge 
of clinical experts with sophisticated analytic techniques may help to improve performance further. 
Richards et al. (2001) and Wyatt (1995) among others have stressed the need for training and 
testing of DM tools to be carried out on independent data sets, and the problems associated with this 
have already been discussed, as well as the need for appropriate training, validating and testing of 
data and systems before implementation in real settings. Lisboa (2002) also recommended that good 
practice be followed in designing models, particularly with respect to ensuring that over-fitting is 
controlled and that appropriate methods are available for variable selection (Tu, 1996). Bias can 
also arise from the minority class problem (MacNamee et al., 2002), in which the majority of cases 
in a data set belong to one class and the other class is significantly under-represented resulting in a 
method (statistical or non-statistical) being very good at identifying the former class but relatively 
poor at identifying the latter class.  
A problem with the development of diagnostic and prognostic tools through DM is that it increases 
the complexity of decision-making for health care professionals (Kononenko et al., 1998), so that 
such tools need to be made as simple to use as possible with user-friendly interfaces.  Lisboa (2002) 
commented that knowing how a model improves accuracy in decision-making is as important as 
whether it improves accuracy and emphasised the need for health care professionals to understand 
how any model works for them to be able to take responsibility for the results it produces. This does 
not only mean understanding basic mathematical principles underlying the models (Koh and Leong, 
2001), but how the models reached particular decisions, the opening of the black box that has 
been previously discussed. While the accuracy/performance of DM tools may be greater than that of 
traditional methods of analysis the lack on information about how they arrive at a decision may not 
be clear because of the black box and because of the complexity of the architecture (Setiono, 1996). 
Although there has been considerable progress in developing sub-symbolic DM tools that are able 
to extract rules to provide an explanation of how they reached their decision-making (Andrews et 
al., 1995), these have not yet been widely adopted for use in health and medicine, and this requires 
further progress.  
A number of authors have identified the need to establish an appropriate evidence base for the use 
of DM tools in medical and health practice, especially when being used for developing tools for 
diagnosis, prognosis, etc. (Cross et al., 1995; Johnston et al., 1994). Lisboa (2002) and Cross et al. 
(1995) discussed the need to compare the performance of DM tools with conventional methods 
before the utility of such techniques could be fully evaluated.  Johnston et al. (1994) identified the 
need to evaluate systematically computer-based decision support systems not only in relation to 
reliability, acceptability and accuracy, but also with respect to improving the clinical behaviour and 
performance of health care professionals, and ultimately to improve patient well-being and patient 
outcomes. While Johnston et al. (1994) acknowledge that the accepted gold standard for evaluating 
healthcare interventions, the randomised controlled trial (RCT), may not always be practical or 
feasible for evaluating computer-based decision support systems that have been developed through 
the use of DM techniques, nevertheless investment in evaluating the effectiveness and efficiency of 
such systems is necessary to maximise the potential benefits and minimise the potential for harm or 
waste that may arise. Lisboa (2002) highlighted the need to evaluate of DM tools through multi-
centre RCTs and to establish an appropriate evidence base for the use of DM tools (Brause, 2001; 
Lisboa, 2002; Anand et al., 1999). 
Downs et al., (1996) highlighted the tension between the need for symbolic rules discovered during 
the DM process to be acceptable to domain experts and the need to demonstrate that the method 
provides new knowledge or understanding in the domain area. Having a means of demonstrating 
how a system arrives at its decision is critical in this respect for both symbolic and sub-symbolic 
methods. Certainly the ability of neural networks to detect lower order relationships previously 
unknown but which can then be tested using statistical models can help gain their acceptance 
among medical and health professionals, and increase their trust when interactions among the data 
are discovered that that cannot be verified using statistical methods (Lisboa, 2002). An additional 
problem is that DM tools may identify and report patterns not accepted and not in line with current 
understanding (Richards et al., 2001, Wyatt, 1995), which may limit their acceptance among health 
care professionals.  
Data mining have been shown to be useful for generating hypotheses for further testing e.g., to 
identify associations or relationships between variables/data that are then tested using conventional 
statistical techniques (Richards et al., 2001). There is a need to focus on the one hand on the way in 
which DM methods can complement the use of statistical techniques in analysing health and 
medical data but also to emphasise the added value that DM methods can bring in the knowledge 
discovery process. Understanding and appreciating the similarities and differences between DM 
tools and statistical methods, and valuing the unique contribution that each makes in improving our 
understanding of the processes underlying health and illness, e.g., while both Cox regression and 
tree-structured survival analysis both allow the identification of risk factors for adverse health 
events, Cox regression can provide an estimate of the strength of these risk factors and tree-
structured analysis helps to identify high risk groups with particular features in common (Carmelli 
et al., 1991). Comparing the performance of different DM and statistical approaches also allows 
different information to be extracted from the data. For example, Lee et al. (2000) compared a 
variety of techniques including correlation analysis, discriminant analysis, data visualisation and 
artificial neural networks to analyses data from a heart disease database, which meant that it was 
possible to identify people at risk of heart disease, risk factors for heart disease and establishing 
multivariate relationships among the predictor variables. Therefore, the maximising the potential of 
data mining may require the use of statistical alongside non-statistical methods.  
Lisboa (2002) commented on the need to ensure that the purpose of studies is clear at the outset. It 
is particularly important to understand the objectives in trying to improve the performance of 
prognosis and diagnosis. Although obtaining 100% accuracy may be the seen as the overall aim, 
this is rarely achieved and the relative importance of sensitivity, specificity positive and negative 
predictive values within the context of clinical care on the relative importance of these evaluation 
measures, as was discussed in the diagnosis of breast cancer. For certain diseases, high sensitivity is 
critical because of the serious, and potentially fatal consequences for an individual of not 
diagnosing an actual case (false negatives) or to ensure that a correct diagnosis is obtained as early 
as possible so that treatment can commence at an early stage in the disease and improve the 
outcomes for patients (Fogel et al., 1997; Fogel et al., 1995). For other diseases, however the 
imperative may be to ensure that the specificity is very high to minimise the number of people who 
are wrongly diagnosed as having the disease and receiving unnecessary treatments (Downs et al., 
1996). On the one hand diagnosing all positive cases may be important to improve survival rates 
reduce co-morbidities. Reducing false positives may be important so that patients are not given 
drugs and medication with potential toxic effects (and high costs) unnecessarily and allowing health 
care professionals to spend maximal time with true cases (Abbass, 2002). 
Bellazi and Zupan (2001) and Liebowitz (2001a) recently discussed the overlap between knowledge 
management and DM, suggesting that DM is an important part of the knowledge management 
process within health care organisations. Data mining relies on the explicit knowledge present in the 
available health and medical literature that is used by clinical researchers, clinicians, 
methodologists and information specialists to help identify appropriate research questions. The 
implicit knowledge of clinicians, health care professionals and health service managers is also 
required for helping to develop and understanding of the data and for evaluating/assessing and 
interpreting the results. The explicit knowledge of clinicians, health care professionals may also be 
embodied into specific DM methods, e.g., Bayesian networks and fuzzy systems, for analysing the 
data (Bellazi and Zupan, 2001). This highlights another important aspect of the use of DM in the 
context of medicine and health in that it requires the multidisciplinary collaboration between health 
and medical professionals and information analysts (Kuo et al., 2001).  
Despite all research and success of DM tools no tools or automated process arising from DM has 
been adopted on a routine basis (Abbass, 2002), Abbass (2002) has proposed several possible 
explanations in that the aim of such systems might be perceived to be to replace the health care 
professional, as well as peoples mistrust and suspicions of technology. This illustrates the need to 
emphasise the complementary nature of DM tools, as an adjunct to decision-making by health and 
medical professionals rather than to replace them (Abbass, 2002). Botacci et al. (1997) emphasised 
the need to combine to use the clinical judgement and experience for careful interpretation of the 
results, and it must be made clear that any data mining tools are just another source of possibly 
useful information (Kononenko et al., 1998, p. 403) that the health care professional may use in 
decision-making with and providing care for patients.  
The point has already been made that data need to be represented in an appropriate format and that 
health care professionals should be able to interpret the results and understand how DM models 
reached their decisions. Lisboa (2002) commented on the increase in DM methods that allow 
visualisation of the data and their potential to assist in the decision-making process and the Growing 
Cell Structure technique demonstrates the value of visualisation (Walker et al., 2002). Human 
beings are better at analysing and interpreting data that are presented visually rather than 
numerically (Walker, 1999; Lisboa, 2002) so that DM models that are able to present a visual image 
of the way in which a decision was made may gain greater acceptability among health care 
professionals. Health care professionals have to trust DM tools, and therefore they need not only to 
understand their performance in terms of accuracy etc., but also in terms of their limitations and 
understand that they are there to aid decision-making by health care professionals not to replace it 
(Cross et al., 1995). In the same way that healthcare professionals build up trust in each other 
through sharing information, decision-making etc., they need to develop trust in the decision-
making tools (Abbass, 2002). This re-emphasises the need for health care professionals, statisticians 
and data miners to collaborate together to improve models and methods of tackling the complex 
issues of analysing health and medical data and overcome the suspicions of the former and any 
over-confidence among the latter (Biganzoli et al., 2002; Kuo et al., 2001). 
Sullivan and Mitchell (1995) discussed the need to evaluate the use of tools from a patient 
perspective and Lisboa (2002) commented the difference between assessing whether a DM model 
improves on the performance of health care professionals and assessing whether there is any overall 
improvement in patient outcomes through the use of tools developed using DM. Although studies 
have demonstrated the effectiveness of DM techniques in terms of diagnostic or prognostic 
accuracy, little research has shown an improvement in patient health and well-being.  
A final, but by no means the least, important consideration in health and medicine is that of ethics. 
Although ethical considerations are of importance in other disciplines they come under particular 
close scrutiny in health and medicine because of its involvement with people, who are often in a 
vulnerable position when being treated for a condition. It is important therefore that any 
developments in DM tools are conducted ethically, with ultimate well being of patients and the 
public in mind, not only in reaching an end, but also in developing the means to achieve this. 
Conclusions 
In this review selected DM and statistical techniques that have been used in medicine and health 
have been examined and their strengths and weaknesses have been discussed. Our understanding of 
the complex processes underlying health and illness is increasing and the available data are 
becoming more numerous and it is becoming possible to integrate and store ever larger volumes in 
data warehouses. As this happens, the demands for appropriate ways of processing these data and 
answering clinically relevant questions will increase as well. The limitations of current ways of 
analysing medical and health data will become more apparent and the search for new and 
alternative methods will intensify. Data mining has the potential to play a part in this. However, to 
achieve greater acceptance and use in clinical settings on a routine basis DM must be seen as a 
systematic process with clear, precise and realistic objectives. The greatest opportunity for DM is 
that it becomes widely recognised as complementary to traditional methods of analysing data in 
health and medicine, and that it can be used alongside, and together with, descriptive and inferential 
statistical methods in the knowledge discovery process, so that the strengths of different techniques 
can be maximised and their weaknesses can be minimised. The development of DM applications 
requires investment of time and resources (Koh and Leong, 2001), but perhaps what is most 
essential is that it is part of a process that involves the multidisciplinary and open-minded 
collaboration of medical and health care professionals, statisticians and information professionals. 
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